MedPage Today on MSN
Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer
Among 16 patients with this difficult-to-treat tumor "with few treatment options," the confirmed overall response rate (ORR) ...
CDR-Life announces early clinical data demonstrating pharmacodynamic activity of CDR404: Zurich, Switzerland Saturday, October 25, 2025, 18:00 Hrs [IST] CDR-Life, Inc, a biotechno ...
The Manila Times on MSN
Ateneo de Manila University using immunoinformatics used to identify promising targets to advance ulcer vaccine
SCIENTISTS at Ateneo de Manila University are now using powerful computer programs to identify promising targets for a ...
In this tough-to-treat cancer type, more patients receiving anzu-cel saw their tumors shrink and had durable responses than what's been seen with other therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback